| 发明名称 |
Pharmaceutical combination |
| 摘要 |
<p>A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior art combination therapies. The invention also provides a pharmaceutical product containing the formulation.</p> |
| 申请公布号 |
AP200804533(D0) |
申请公布日期 |
2008.08.31 |
| 申请号 |
AP20080004533 |
申请日期 |
2006.12.14 |
| 申请人 |
CIPLA LIMITED |
发明人 |
LULLA AMAR;MALHOTRA GEENA |
| 分类号 |
A61K9/24;A61K31/496;A61K31/536;A61K31/7068;A61K31/7072;A61K45/06;A61P31/18 |
主分类号 |
A61K9/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
